Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,213 | 17,483 | 17,868 | 14,980 | 14,697 |
| Marketable Securities | 52,413 | 75,364 | 89,713 | 102,590 | 112,451 |
| TOTAL | $73,647 | $94,616 | $109,611 | $120,156 | $129,690 |
| Non-Current Assets | |||||
| PPE Net | 97 | 2,940 | 3,216 | 3,499 | 3,794 |
| Other Non-Current Assets | 0 | 43,414 | 44,232 | 45,066 | 45,969 |
| TOTAL | $97 | $46,354 | $47,448 | $48,565 | $49,763 |
| Total Assets | $73,744 | $140,970 | $157,059 | $168,721 | $179,453 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,995 | 5,710 | 6,727 | 6,773 | 5,855 |
| Accrued Expenses | 2,773 | 589 | 2,643 | 2,020 | 1,397 |
| TOTAL | $7,768 | $9,583 | $12,537 | $11,845 | $9,213 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $45,004 | $45,868 | $46,707 | $47,549 |
| Total Liabilities | $7,768 | $54,587 | $58,405 | $58,552 | $56,762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,748 | 22,464 | 22,407 | 22,386 | 22,386 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -296,917 | -273,224 | -259,669 | -246,784 | -232,905 |
| Other shareholders' equity | -32 | -23 | 64 | 50 | -4 |
| TOTAL | $65,976 | $86,383 | $98,654 | $110,169 | $122,691 |
| Total Liabilities And Equity | $73,744 | $140,970 | $157,059 | $168,721 | $179,453 |